CLEMENT PHARMA
0423.344.820 · rovalta.com · 09/11/2026
CLEMENT PHARMA
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOCLEMENT PHARMA is a Public limited company incorporated in 1982. Its main activity is: Manufacture of furniture. Its registered office is in Izegem. It employs on average 16,6 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0423.344.820
- Incorporation
- 23/12/1982
- Legal form
- Public limited company
- Registered office
- Lodewijk de Raetlaan 16 box 2
8870 Izegem · FlandreSee on map - Contributed capital
- 62 000,00 €
- Latest accounts
- 31/12/2025
- Average workforce
- 16,6 ETP
Joint committees (5)
- 100
- 1000
- 200
- 2000
- 218
Financials
Source · NBB, 20 filingsTrend over 17 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 1,1 M € | -6.5% | 1,2 M € | +7.6% | 1,1 M € | -11.1% | 1,2 M € | +53.6% | 800,8 k € |
| EBITDA | -97,2 k € | -186% | 113,5 k € | +131% | 49 k € | -88.4% | 421 k € | +825% | 45,5 k € |
| Operating result | -143,1 k € | -285% | 77,5 k € | +483% | 13,3 k € | -96.5% | 383,1 k € | +6957% | 5,4 k € |
| Net result | -160,5 k € | -439% | 47,3 k € | +2548% | -1,9 k € | -101% | 272,2 k € | +7322% | -3,8 k € |
| Balance sheet | |||||||||
| Equity | 860,6 k € | -15.7% | 1 M € | +4.9% | 973,8 k € | -0.2% | 975,7 k € | +38.7% | 703,5 k € |
| Total assets | 1,3 M € | -11.8% | 1,5 M € | -6.9% | 1,6 M € | +6.1% | 1,5 M € | +48.7% | 1 M € |
| Cash | 489 k € | +223% | 151,6 k € | +2.4% | 148 k € | -66.7% | 445,2 k € | +442% | 82,2 k € |
| Debts | 451,9 k € | -3.1% | 466,6 k € | -25.2% | 623,9 k € | +17.7% | 530,2 k € | +71.6% | 308,9 k € |
| Other | |||||||||
| Workforce | 16,6 ETP | +4.4% | 15,9 ETP | +6.7% | 14,9 ETP | +10.4% | 13,5 ETP | +7.1% | 12,6 ETP |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20252 active · 3 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
4 GC SARL naar Luxemburgs recht | Managing directorsince 28/06/2025 | ||
| Managing directorChairman of the board of directors28/01/2008 → 2019 accountsendedDirector2023 accountsended |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Denise Bouckaert | Director28/06/2018 → 2019 accounts | ||
Erik Clement | Directoruntil 15/02/2017 |
Other companies at this address
Lodewijk de Raetlaan 16 8870 IzegemFinancials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 14/08/2026 | 16/07/2025 | 24/07/2024 | 30/05/2023 | 27/06/2022 | 23/07/2021 |
| General meeting | 30/06/2026 | 28/06/2025 | 29/06/2024 | 27/05/2023 | 28/05/2022 | 29/05/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 20 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 30/06/2026 | 14/08/2026 | Dutch | |
| Abridged model | 31/12/2024 | 28/06/2025 | 16/07/2025 | Dutch | |
| Abridged model | 31/12/2023 | 29/06/2024 | 24/07/2024 | Dutch | |
| Abridged model | 31/12/2022 | 27/05/2023 | 30/05/2023 | Dutch | |
| Abridged model | 31/12/2021 | 28/05/2022 | 27/06/2022 | Dutch | |
| Abridged model | 31/12/2020 | 29/05/2021 | 23/07/2021 | Dutch | |
| Abridged model | 31/12/2019 | 30/05/2020 | 24/06/2020 | Dutch | |
| Abridged model | 31/12/2018 | 29/06/2019 | 16/07/2019 | Dutch | |
| Abridged model | 31/12/2017 | 28/06/2018 | 20/07/2018 | Dutch | |
| Abridged model | 31/12/2016 | 27/05/2017 | 26/06/2017 | Dutch | |
| Full model | 31/12/2015 | 28/05/2016 | 30/05/2016 | Dutch | |
| Full model | 31/12/2014 | 30/05/2015 | 23/06/2015 | Dutch | |
| Full model | 31/12/2013 | 31/05/2014 | 25/06/2014 | Dutch | |
| Full model | 31/12/2012 | 25/05/2013 | 17/06/2013 | Dutch | |
| Full model | 31/12/2011 | 30/06/2012 | 24/07/2012 | Dutch | |
| Full model | 31/12/2010 | 28/05/2011 | 24/06/2011 | Dutch | |
| Full model | 31/12/2009 | 29/05/2010 | 15/06/2010 | Dutch | |
| Full model | 31/12/2008 | 30/05/2009 | 05/06/2009 | Dutch | |
| Full model | 31/12/2007 | 31/05/2008 | 01/07/2008 | Dutch | |
| Full model | 31/12/2006 | 15/03/2007 | 30/03/2007 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 500 k€ and 1 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20252 active · 3 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
4 GC SARL naar Luxemburgs recht | Managing directorsince 28/06/2025 | ||
| Managing directorChairman of the board of directors28/01/2008 → 2019 accountsendedDirector2023 accountsended |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Denise Bouckaert | Director28/06/2018 → 2019 accounts | ||
Erik Clement | Directoruntil 15/02/2017 |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates15/09/2025ONTSLAGEN - BENOEMINGEN
- Mandates05/10/2023STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - DIVERSEN - DOEL - KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN - ALGEMENE VERGADERING
- Mandates28/09/2020ONTSLAGEN - BENOEMINGEN
- Mandates14/09/2017VASTSTELLING EINDE MANDAAT BESTUURDER
- Other23/01/2014Akteneming wijziging vaste vertegenwoordiger
- Mandates27/08/2012ONTSLAGEN - BENOEMINGEN
- Mandates15/02/2008Vaststelling ontslag bestuurder / voorzitter directeur - benoeming
- Mandates06/07/2006« BEEINDIGING MANDATEN/(HER)BENOEMING BESTUURDERS-
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsRegistered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Lodewijk de Raetlaan 16 bte 2, 8870 IzegemCurrent | accounts 2023 → 2025 | Accounts 2025 · 2026-00398457 |
| Lodewijk de Raetlaan 16/2, 8870 Izegem | accounts 2021 → 2022 | Accounts 2022 · 2023-00098213 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| CLEMENT PHARMACurrent | accounts 2007 → 2025 | Accounts 2025 · 2026-00398457 |
Events
- 2025Annual accounts 2025-160,5 k €↓
- 2024Annual accounts 202447,3 k €↑
- 2023Annual accounts 2023-1,9 k €↓
- 2022Annual accounts 2022272,2 k €↑
- 2021Annual accounts 2021-3,8 k €↑
- 2018Annual accounts 2018-18,4 k €↑
- 2017Annual accounts 2017-22,6 k €↓
- 2016Annual accounts 20161,6 k €↓
- 2015Annual accounts 2015242,7 k €↑
- 2014Annual accounts 20143,6 k €↓
- 2013Annual accounts 201311,2 k €↓
- 2012Annual accounts 201225,2 k €↓
- 2011Annual accounts 2011173,5 k €↓
- 2010Annual accounts 2010248,8 k €↑
- 2009Annual accounts 2009212,3 k €↓
- 2008Annual accounts 2008300,8 k €↓
- 2007Annual accounts 2007360,8 k €
- 23/12/1982IncorporationPublic limited company